Targeting urothelium: Ex vivo assay standardization and selection of internalizing ligands

Peter U ARDELT; Christopher G WOOD; Limor CHEN; Paul J MINTZ; Catherine MOYA; Marco A ARAP; Kenneth C WRIGHT; Renata PASQUALINI; Wadih ARAP

doi:10.1097/01.ju.0000055477.37115.66

Back

Targeting urothelium: Ex vivo assay standardization and selection of internalizing ligands

Conference proceeding

Peer reviewed

Targeting urothelium: Ex vivo assay standardization and selection of internalizing ligands

Peter U ARDELT, Christopher G WOOD, Limor CHEN, Paul J MINTZ, Catherine MOYA, Marco A ARAP, Kenneth C WRIGHT, Renata PASQUALINI and Wadih ARAP

The Journal of urology, Vol.169(4), pp.1535-1540

AUA Program Abstracts: American Urological Association, 2003 Annual Meeting, April 16-May 1, 2003, Chicago

2003

DOI: https://doi.org/10.1097/01.ju.0000055477.37115.66

PMID: 12629410

Abstract

Tumors of the urinary system

Urinary tract. Prostate gland

Investigative techniques, diagnostic techniques (general aspects)

Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques

Urinary system

Nephrology. Urinary tract diseases

Biological and medical sciences

Medical sciences

Metrics

7 Record Views

23 Times Cited - Web of Science

Details

Title: Targeting urothelium: Ex vivo assay standardization and selection of internalizing ligands
Creators: Peter U ARDELT - Departments of Genitourinary Medical Oncology, Urology, Experimental Diagnostic Radiology and Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States
Christopher G WOOD - Departments of Genitourinary Medical Oncology, Urology, Experimental Diagnostic Radiology and Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States
Limor CHEN - Departments of Genitourinary Medical Oncology, Urology, Experimental Diagnostic Radiology and Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States
Paul J MINTZ - Departments of Genitourinary Medical Oncology, Urology, Experimental Diagnostic Radiology and Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States
Catherine MOYA - Departments of Genitourinary Medical Oncology, Urology, Experimental Diagnostic Radiology and Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States
Marco A ARAP - Departments of Genitourinary Medical Oncology, Urology, Experimental Diagnostic Radiology and Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States
Kenneth C WRIGHT - Departments of Genitourinary Medical Oncology, Urology, Experimental Diagnostic Radiology and Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States
Renata PASQUALINI - Departments of Genitourinary Medical Oncology, Urology, Experimental Diagnostic Radiology and Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States
Wadih ARAP - Departments of Genitourinary Medical Oncology, Urology, Experimental Diagnostic Radiology and Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States
Publication Details: The Journal of urology, Vol.169(4), pp.1535-1540
Conference: AUA Program Abstracts: American Urological Association, 2003 Annual Meeting, April 16-May 1, 2003, Chicago
Date published: 2003
Publisher: Lippincott Williams & Wilkins
Grant note: American Urological Association
Academic Unit: Radiation Oncology; Cancer Institute of New Jersey at University Hospital
Language: English
Resource Type: Conference proceeding
Identifiers: 991031654613904646